Announcements, News
Aterian Investment Partners Acquires Contract Pharmaceuticals Limited
New York and Miami, June 6, 2024 – Aterian Investment Partners (“Aterian”), a private investment firm, is pleased to announce that one of its affiliates has closed its acquisition of Contract Pharmaceuticals Limited Canada (“CPL” or the “Company”), a leading North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid dosage forms. […]
News
CPL’S SENIOR MANAGER OF FORMULATION DEVELOPMENT, CHETAN CHURE, PRESENTS POSTER AT AAPS 2023 PHARMSCI 360
CPL’s Senior Manager of Formulation Development, Chetan Chure, recently attended AAPS 2023 PharmSci 360 and presented his poster, “Design, Development, and Evaluation of Novel Extended-Release Liposomal Topical Cream Formulation of Pregabalin Using Microemulsion Technique for the Treatment of Local Neuropathic Pain”. To view the poster, please click the link below: Poster – AAPS 2023 PharmSci 360
Announcements, News
CONTRACT PHARMACEUTICALS LIMITED (CPL) WELCOMES LUCY ZHAO AS MANAGER OF THE SKIN LAB
June 13, 2023 – Mississauga, Ontario. CPL, a leading contract development and manufacturing organization (CDMO) of non-sterile liquid and topical drug products, is thrilled to welcome Lucy Zhao as the Manager of the Skin Lab within our Product Development Services team. With a career spanning over 15 years, Lucy brings an impressive track record of success […]
Announcements, News
CPL Completes Successful Regulatory Inspections from Canadian and Brazilian Health Agencies
May 19, 2023 – Mississauga, Ontario. CPL, a leading contract development and manufacturing organization (CDMO) of non-sterile liquid and topical drug products, recently completed successful inspections of its Mississauga facilities by both the Brazilian Regulatory Authority (ANVISA) and Health Canada. Health Canada performed a routine inspection of CPL’s Meadowpine facility which includes the Quality Control analytical testing […]
News
CPL’s Chetan Chure & Contract Pharma discuss development of a semi-solid drug formulation
CPL’s Senior Manager of Formulation Development, Chetan Chure, recently sat down with Contract Pharma to discuss common challenges encountered during development of a semi-solid drug formulation, CPL’s approach to creating a stable drug product, and formulation scale-up. Please follow the link to watch the video of that discussion. Contact us
News
CPL expands capacity to perform GMP in vitro Permeation Testing (IVPT)
IVPT generates the permeation profile of an active molecule in a specific drug formulation and tells us how much of the applied drug is entering the skin and passing through the different layers of the skin. IVPT provides crucial information about how much of the applied drug is entering the skin and its localization within […]
News
CPL receives EcoVadis Silver Medal for Corporate Social Responsibility (CSR)
A CSR assessment is an evaluation of how well a company has integrated corporate social responsibility (CSR) into its business. CSR is a business model that encourages companies to consider and address issues related to the environment, labor and human rights, ethics, and sustainable procurement. By completing a CSR assessment, CPL understands how we are performing […]
Announcements, News
Contract Pharmaceuticals Limited appoints Jan Sahai as Chief Executive Officer
Press Release Mississauga, Ontario, January 18, 2023 – The Board of Directors of Contract Pharmaceuticals Limited (CPL) is pleased to appoint Jan Sahai, MBA, PharmD as Chief Executive Officer, effective immediately, reporting to Caitlin Wege, Executive Chair, Board of Directors. Since joining CPL in 2005 as head of business development, Jan has grown our […]
News
CPL’S SHANNON MEIJER DOES A DEEP DIVE ON EMPLOYEE ENGAGEMENT WITH BUCKETLIST
CPL’s VP of Human Resources, Shannon Meijer, recently sat down with Bucketlist Rewards and Recognition to discuss how Recognition and Rewards programs can drive employee engagement. Click below to watch the webinar and learn tangible strategies to build an engaging workplace culture: Contact us
News
CPL’s David Tyler sits down with Contract Pharma
CPL’s Director of Business Development, David Tyler, recently sat down with Contract Pharma to discuss the importance of outsourcing and trends within the CDMO environment. Please follow the link below to watch the interview: https://www.contractpharma.com/contents/view_breaking-news/2022-10-17/david-tyler-of-cpl-sits-down-with-contract-pharma/?widget=listSection Contact us